Home › NDC Lookup › Ingredients › Petrolatum › 76176-0023-01
💊image loading
(from DailyMed)

Personal Care Creamy Cocoa Butter Petroleum Petrolatum 30 g/100g Jelly, 128 g — NDC 76176-023-01 (Billing 76176-0023-01)

by Ningbo Liyuan Daily Chemical Products Co.,Ltd. · 128 g in 1 TUBE

This is a package of 128 g of Personal Care Creamy Cocoa Butter Petroleum Petrolatum 30 g/100g Jelly from Ningbo Liyuan Daily Chemical Products Co.,Ltd., no longer marketed (first marketed Jan 2023), no longer in the FDA NDC Directory. It is this product's only package size.

NDC 76176-0023-01
🏷️ FDA NDC (as labeled) 76176-023-01 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Dec 2024. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 76176-023-01
Product NDC 76176-023
11-digit billing NDC 76176002301
RxCUI 1037285
UNII 4T6H12BN9U
UPC 0048155922242
Application # M016
SPL Set ID 1b277759-6629-0eac-e063-6394a90a30d2
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Dec 2024)
Marketing start 2023-01-01
Route TOPICAL
Dosage form JELLY
Substance PETROLATUM
Quick answers
  • RxCUI (RxNorm): 1037285
Why two NDCs? The FDA registers this code as 76176-023-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 76176-0023-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an over-the-counter topical jelly marketed as an OTC monograph drug under FDA's established rule-book for skin protectants. The active ingredient is petrolatum, an occlusive moisturizer commonly used to protect and soften dry or irritated skin. The product is formulated with cocoa butter for fragrance and texture and is applied directly to the skin as needed.

Supplement & herbal interactions

Some supplements/herbs that may interact with Petrolatum — tap one for details:

Dimethylsulfoxide (dmso)Moderate Turpentine OilModerate AlchemillaMinor
🌿 Every supplement checked against Petrolatum (3 interactions) — ranked by severity →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
76176-0023-01 You're viewing this Main listing 128 g in 1 TUBE 2023-01-01 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
PETROLEUM jelly 30 g/100mL 52000-0123-34 Universal 133 ml — — FDA listed —
COCOA BUTTER PETROLEUM jelly 30 g/100mL 52000-0124-35 Universal 133 ml — — FDA listed —
XtraCare Creamy Petroleum Jelly 38 g/127g 57337-0060-01 Rejoice 127 g — — FDA listed —
XtraCare Creamy Petroleum Jelly 38 g/127g 57337-0061-01 Rejoice 127 g — — FDA listed —
Royal Creamy Petroleum Jelly 30 g/100g 73597-0012-07 Mission 198 g — — FDA listed —
Royal Creamy Petroleum Jelly Cocoa Butter 30 g/100g 73597-0014-07 Mission 198 g — — FDA listed —
Royal Creamy Petroleum Jelly 30 g/100g 73597-0028-07 Mission 198 g — — Discontinued —
Royal Creamy Petroleum Jelly Cocoa Butter 30 g/100g 73597-0029-07 Mission 198 g — — Discontinued —
Personal Care Creamy Petroleum 30 g/100g 76176-0022-01 Ningbo 128 g — — Discontinued —
Personal Care Creamy Cocoa Butter Petroleum 30 g/100gthis 76176-0023-01 Ningbo 128 g — — Discontinued —
Cruex Petroleum Jelly 30 g/100g 77782-0004-13 MKJ 113 g — — FDA listed —
Creamy Petroleum 30 g/100g 83650-0103-01 Savvy 133 g — — FDA listed —
COCOA BUTTER PETROLEUM jelly 30 g/100mL 83650-0104-01 Savvy 133 ml — — FDA listed —
Petrolatum 30 g/100g 33992-0498-01 Greenbrier 85 g — — FDA listed —
Petrolatum 30 g/100g 33992-0499-01 Greenbrier 85 g — — FDA listed —
Aquaphor Healing Balm Stick 30 g/100g 10356-0125-55 Beiersdorf 18.4 g — — FDA listed —
Royal Creamy Petroelum 30 g/100g 85891-0011-01 SPARROW 24 tubes — — Discontinued —
Baby Balm Stick 0.65oz 30 g/100g 57337-0167-01 Rejoice 18.4 g — — FDA listed —
CareALL Creamy Petroleum Jelly 30 g/100g 51824-0082-03 New 85 g — — FDA listed —
CareALL Creamy Cocoa Butter Petroleum Jelly 30 g/100g 51824-0083-03 New 85 g — — FDA listed —
Advanced Healing Balm 30 g/100g 57337-0192-01 Rejoice 18.4 g — — FDA listed —
Royal Creamy Petroelum Intensive Care Cocoa Scent 30 g/100g 85891-0013-01 SPARROW 24 tubes — — Discontinued —
Walgreens Baby Healing Balm 30 g/100g 00363-2823-01 Walgreens 50 g — — FDA listed —
OKeeffes Lip Repair SEAL and HEAL 30 g/100g 71564-0011-22 The 2 cylinders — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Jan 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerNingbo Liyuan Daily Chemical Products Co.,Ltd.
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code76176
First marketedJan 2023
Product typeHuman Otc Drug
Portfolio5 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 27 words ▾

Uses temporarily protects minor: cuts, scrapes, burns. temporarily protects and helps relieve chapped or cracked skin. helps protect from the drying effects of wind and cold weather.

⏱️ Dosage and Administration 4 words ▾

Directions apply as needed.

⚠️ Warnings 51 words ▾

Warnings For external use only. When using this product do not get into eyes. Stop use and ask a doctor if condition worsens, symptoms last more than 7 days or clear up and occur again within a few days. Do not use on deep or puncture wounds, animal bites, serious burns.

🧪 Active Ingredient 6 words ▾

Drug Facts Active ingredient Petrolatum 30%

🧪 Inactive Ingredients 24 words ▾

Inactive ingredients water, cetearyl alcohol, glycerin, stearic acid, sodium lauryl sulfate, triethanolamine, carbomer, theobroma cacao (cocoa) seed butter, tocopheryl acetate, fragrance, methylisothiazolinone, iodopropynyl butylcarbamate

🎯 Purpose 3 words ▾

Purpose Skin protectant

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 1 words ▾

printing

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for PETROLATUM — the ingredient across all brands.

Top reported reactions

Eye Irritation358
Eye Pain333
Vision Blurred263
Ocular Hyperaemia229
Dry Eye218
Nausea139
Diarrhoea134

Age at onset

Neonate7
Infant11
Child23
Adolescent16
Adult252
Elderly356

Reporter sex

3,432 reports
Male · 36%
Female · 64%
Unknown · 0%

Serious outcomes

Hospitalization988
Death277
Life-threatening173
Disabling84
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 255 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Ningbo Liyuan Daily Chemical Products Co.,Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 76176-0022-01 · Ningbo 76176-0024-01 · NINGBO →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.